Skip to main content

Together we are beating cancer

Donate now

Search Results: immunotherapy

Showing 12 out of 584 results
A time-lapse image showing a dividing cell.

Evolution is the power behind cancer. It might also be our best way to stop it. We’re unlocking insights to make sure that when cancer evolves, science evolves faster. Evolution is the power behind cancer. It might also be our best way to stop it. We’re unlocking insights to make sure that when cancer evolves, science evolves faster.

by Tim Gunn | In depth | 26 March 2026

26 March 2026

Confocal micrograph of highly invasive tumour cells derived from a rare paediatric brain tumour.

A discovery at the Cancer Research UK Cambridge Institute could lead to an immunotherapy for treating multiple types of brain tumours in children and young people. A discovery at the Cancer Research UK Cambridge Institute could lead to an immunotherapy for treating multiple types of brain tumours in children and young people.

by Sophie Wedekind | Analysis | 18 March 2026

18 March 2026

Three researchers in blue labcoats.

Cancer Grand Challenges has awarded five global research teams up to £20m each to help us overcome some of the biggest obstacles in the way of against cancer. Cancer Grand Challenges has awarded five global research teams up to £20m each to help us overcome some of the biggest obstacles in the way of against cancer.

by Tim Gunn | In depth, News | 4 March 2026

4 March 2026

Researcher in the lab.

Two years ago, we launched our More Research, Less Cancer campaign. Today, we’re past the halfway point of the campaign. Read about our impact so far. Two years ago, we launched our More Research, Less Cancer campaign. Today, we’re past the halfway point of the campaign. Read about our impact so far.

by Krishna Sharma | Philanthropy and partnerships | 23 February 2026

23 February 2026

Adeno-associated Virus,

Advances in viral gene delivery – and a side project that paid off – have sent a highly targeted glioblastoma immunotherapy heading toward the clinic... Advances in viral gene delivery – and a side project that paid off – have sent a highly targeted glioblastoma immunotherapy heading toward the clinic...

by Cancer Research UK | In depth | 6 January 2026

6 January 2026

2D image of scientist hands with a cancer vaccine vial and needle
  • Health & Medicine
  • Science & Technology

Cancer Vaccines - where are we?

Cancer vaccine development has had many challenges. But with recent breakthroughs, new partnerships and current clinical trials, could we be closer than ever? Cancer vaccine development has had many challenges. But with recent breakthroughs, new partnerships and current clinical trials, could we be closer than ever?

by Sophie Wedekind | In depth | 20 November 2025

20 November 2025

Hand in a glove holding a scalpel.

Cancer surgery has been around for thousands of years. Now, we're bringing it into the 21st century with light-up dyes, lasers and robots. Cancer surgery has been around for thousands of years. Now, we're bringing it into the 21st century with light-up dyes, lasers and robots.

by Nisharnthi Duggan | Analysis | 19 November 2025

19 November 2025

Cells and DNA in blood
  • Health & Medicine
  • Science & Technology

What are liquid biopsies?

There’s a treasure trove of information in our blood, urine and saliva. We're using it to find and understand cancer. There’s a treasure trove of information in our blood, urine and saliva. We're using it to find and understand cancer.

by Emily Farthing | In depth | 13 November 2025

13 November 2025

A cluster of different sized pink cells seen through a microscope.

Our researchers discovered that EGFR, a molecule produced by our cells, can fuel cancer growth. This breakthrough led to the development of targeted treatments that attack cancer at its source. Our researchers discovered that EGFR, a molecule produced by our cells, can fuel cancer growth. This breakthrough led to the development of targeted treatments that attack cancer at its source.

by Henry Scowcroft | In depth | 13 November 2025

13 November 2025

Microscope image showing the cells in different layers of skin. It appears pink, blue, purple and red.
  • Science & Technology
  • Health & Medicine

Skin cancer 101: what everyone should know

We’re answering some of the biggest questions about skin cancer and exploring some of the ways we're making progress for people affected by the disease. We’re answering some of the biggest questions about skin cancer and exploring some of the ways we're making progress for people affected by the disease.

by Tim Gunn | In depth | 12 June 2025

12 June 2025

Samra Turajlic (credit: Michael Bowles)

Meet the lead of a new multi-million pound collaboration to make immunotherapy work for more people Meet the lead of a new multi-million pound collaboration to make immunotherapy work for more people

by Krishna Sharma | 23 May 2025

23 May 2025

A microscope image showing purple cancer cells against a black background.

PRRDetect, developed by scientists at the University of Cambridge, picks out cancers that are vulnerable to immunotherapy by scanning for mutation patterns. PRRDetect, developed by scientists at the University of Cambridge, picks out cancers that are vulnerable to immunotherapy by scanning for mutation patterns.

by Amal Iman, Tim Gunn | News | 10 April 2025

10 April 2025